ERIS.BO Earnings — Eris Lifesciences Limited

BSE

Updated Oct 30, 2026

Price —

Market Cap $162.4B

P/E 23.4

52W Range — – —

When is ERIS.BO's next earnings date?

Eris Lifesciences Limited (ERIS.BO) has not announced its next earnings date yet. Its most recent earnings report was on Monday, October 26, 2026.

How did ERIS.BO do in its last earnings report?

In its most recent report on Oct 26, 2026, Eris Lifesciences Limited posted EPS of $13.30 versus the $10.62 estimate, a beat. Revenue was $8.92B against a $8.88B estimate.

How much does ERIS.BO stock move after earnings?

ERIS.BO beat EPS estimates in 1 of its last 2 reported quarters.

About Eris Lifesciences Limited

Eris Lifesciences Ltd., along with its affiliated companies, operates in India, specializing in the production, promotion, and supply of proprietary pharmaceutical drugs aimed at treating chronic and semi-chronic health conditions. The company's extensive product portfolio encompasses a wide array of branded formulations across numerous therapeutic categories, including treatments for diabetes, infections, cardiovascular ailments, dermatological issues, digestive disorders, blood-related conditions, hormonal imbalances, central nervous system disorders, neuropsychiatric conditions, ear complaints, pain relief, respiratory illnesses, oral health, cosmetic applications, women's health, and essential vitamins/minerals/nutrients. Furthermore, Eris provides vital patient support services, such as blood pressure measurement, portable electrocardiogram monitoring, continuous glucose tracking, sleep evaluations, and prenatal care programs. Its pharmaceutical offerings reach consumers via a robust distribution network comprising wholesale drug distributors, stockists, and retail pharmacies. Established in 2007, Eris Lifesciences Limited maintains its headquarters in Ahmedabad, India.

🤖 AI Earnings Analysis

ERIS.BO combines a 19.8% profit margin with a 23.3× P/E, indicating solid profitability at a valuation investors should weigh against growth prospects.

AI-generated summary — powered by BigEarnings.